Within this podcast, Improving Provider Confidence in Patient Identification and the Administration of Oncolytic Viral Therapy, Dr. Howard Kaufman and Dr. Anna C. Pavlick examine the patient and tumor characteristics that may make a patient wit

Mechanisms of Oncolytic Viral Therapy With Drs. Howard Kaufman and Kevin Harrington

Apr 25th, 2021 18m 17s

Within this podcast, Mechanisms of Oncolytic Viral Therapy, Dr. Howard Kaufman and Professor Kevin Harrington review the rationale for the use of oncolytic viral therapies as monotherapy or in combination with checkpoint inhibitors for patients

Overview of Oncolytic Viral Therapy – Focus on Melanoma With Drs. Howard Kaufman and Dmitriy Zamarin

Apr 25th, 2021 15m 25s

Within this podcast, Overview of Oncolytic Viral Therapy – Focus on Melanoma, Dr. Howard Kaufman and Dr. Dmitriy Zamarin evaluate the latest advances regarding the use of oncolytic viral therapy for cancer management, particularly in the contex

Harnessing Shared Decision-making in Patients With Hemophilia A With Regina Butler, RN-BC and Courtney Thornburg, MD

Nov 25th, 2020 13m 10s

In this podcast, expert clinicians review strategies to engage patients with hemophilia A in their own care to improve overall patient satisfaction.

Communicating With Patients for Optimized Hemophilia A Care With Regina Butler, RN-BC and Patient Advocate, Charles Felthaus

Nov 25th, 2020 13m 39s

In this podcast, a clinician and patient discuss his experience with hemophilia A, addressing patient concerns regarding this condition, its management, and preferred communication methods.

New Treatment Options to Overcome Challenges in Hemophilia A Management With Regina Butler, RN-BC and Michael Callaghan, MD

Nov 25th, 2020 14m 8s

In this podcast, expert clinicians discuss recent and emerging treatment options with the potential to benefit patients with and without inhibitors.

Historical Challenges Associated With Hemophilia A Management With Regina Butler, RN-BC and Guy Young, MD

Nov 25th, 2020 15m

In this podcast, expert clinicians discuss historical challenges in hemophilia A care and how recent therapeutic advancements help to overcome these limitations.

Trailer

Hemophilia A: Incorporating New Therapeutic Strategies to Address Historical Treatment Challenges

Nov 24th, 2020 1m 7s

Hemophilia A is an X-linked recessive disease primarily affecting males. An estimated 20,000 individuals in the United States have the disease. Conventional standard of care for patients with severe disease is factor VIII administration given p

Rate